Showing results (281-290 of 306) with videos related to

Sort By:
Pageof 31
Physical Review Letters|August 16, 2006
Single-atom optical clock with high accuracyW H Oskay, S A Diddams, E A Donley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2020
Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV)Irena Rohr, Sara Alavi, Rolf Richter, et al.
Clinical Cardiology|May 21, 2026
Rationale and Design of the Türkiye Heart Failure (TURK-HF) RegistryUmut Kocabas, Selda Murat, Tarık Kıvrak, et al.
BMC Cancer|September 13, 2021
Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in GermanyD Dimitrova, B Naghavi, R Richter, et al.
Gynecologic Oncology Research and Practice|March 14, 2017
Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trialRadoslav Chekerov, Philipp Harter, Stefan Fuxius, et al.
Journal of Clinical Immunology|October 21, 2025
Beyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX PatientsIsmail Yaz, Sevil Oskay Halacli, Canberk Ipsir, et al.
Physical Review Letters|March 16, 2007
Precision atomic spectroscopy for improved limits on variation of the fine structure constant and local position invarianceT M Fortier, N Ashby, J C Bergquist, et al.
The Lancet. Oncology|August 14, 2018
Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialRadoslav Chekerov, Felix Hilpert, Sven Mahner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study GroupJalid Sehouli, Dirk Stengel, Philipp Harter, et al.
Archives of Gynecology and Obstetrics|January 6, 2026
Between research and introduction to clinical routine-Experience with niraparib from the compassionate use program in Germany (NOGGO Register Analysis)Jacek P Grabowski, Julia Welz, Sabine Heublein, et al.
Pageof 31